| Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12 … YK Kang, N Boku, T Satoh, MH Ryu, Y Chao, K Kato, HC Chung, JS Chen, ... The Lancet 390 (10111), 2461-2471, 2017 | 2112 | 2017 |
| Nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastro-oesophageal … YK Kang, LT Chen, MH Ryu, DY Oh, SC Oh, HC Chung, KW Lee, T Omori, ... The Lancet Oncology 23 (2), 234-247, 2022 | 383 | 2022 |
| Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a … RK Kelley, M Ueno, C Yoo, RS Finn, J Furuse, Z Ren, T Yau, HJ Klümpen, ... The Lancet 401 (10391), 1853-1865, 2023 | 258 | 2023 |
| A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data LT Chen, T Satoh, MH Ryu, Y Chao, K Kato, HC Chung, JS Chen, K Muro, ... Gastric cancer 23, 510-519, 2020 | 189 | 2020 |
| LBA7_PR Nivolumab plus chemotherapy versus chemotherapy alone in patients with previously untreated advanced or recurrent gastric/gastroesophageal junction (G/GEJ) cancer … N Boku, MH Ryu, DY Oh, SC Oh, HC Chung, KW Lee, T Omori, K Shitara, ... Annals of Oncology 31, S1192, 2020 | 157 | 2020 |
| A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer JS Chen, C Hsu, NJ Chiang, CS Tsai, HH Tsou, SF Huang, LY Bai, ... Annals of oncology 26 (5), 943-949, 2015 | 143 | 2015 |
| Identification and characterization of a novel integrin-linked kinase inhibitor SL Lee, EC Hsu, CC Chou, HC Chuang, LY Bai, SK Kulp, CS Chen Journal of medicinal chemistry 54 (18), 6364-6374, 2011 | 114 | 2011 |
| Retinoblastoma in Taiwan: survival rate and prognostic factors CY Chang, TJ Chiou, B Hwang, LY Bai, WM Hsu, YL Hsieh Japanese journal of ophthalmology 50, 242-249, 2006 | 107 | 2006 |
| Pharmacological exploitation of the phenothiazine antipsychotics to develop novel antitumor agents–A drug repurposing strategy CH Wu, LY Bai, MH Tsai, PC Chu, CF Chiu, MY Chen, SJ Chiu, ... Scientific reports 6 (1), 27540, 2016 | 91 | 2016 |
| Cucurbitane Triterpenoid from Momordica charantia Induces Apoptosis and Autophagy in Breast Cancer Cells, in Part, through Peroxisome Proliferator‐Activated Receptor … JR Weng, LY Bai, CF Chiu, JL Hu, SJ Chiu, CY Wu Evidence‐Based Complementary and Alternative Medicine 2013 (1), 935675, 2013 | 89 | 2013 |
| Follicular dendritic cell tumor of the liver associated with Epstein–Barr virus LY Bai, WK Kwang, IP Chiang, PM Chen Japanese journal of clinical oncology 36 (4), 249-253, 2006 | 86 | 2006 |
| Targeted nanoparticle delivery overcomes off-target immunostimulatory effects of oligonucleotides and improves therapeutic efficacy in chronic lymphocytic leukemia B Yu, Y Mao, LY Bai, SEM Herman, X Wang, A Ramanunni, Y Jin, X Mo, ... Blood, The Journal of the American Society of Hematology 121 (1), 136-147, 2013 | 85 | 2013 |
| Exploring markers of exhausted CD8 T cells to predict response to immune checkpoint inhibitor therapy for hepatocellular carcinoma CL Hsu, DL Ou, LY Bai, CW Chen, L Lin, SF Huang, AL Cheng, YM Jeng, ... Liver cancer 10 (4), 346-359, 2021 | 79 | 2021 |
| Nivolumab in previously treated advanced gastric cancer (ATTRACTION-2): 3-year update and outcome of treatment beyond progression with nivolumab N Boku, T Satoh, MH Ryu, Y Chao, K Kato, HC Chung, JS Chen, K Muro, ... Gastric cancer 24, 946-958, 2021 | 70 | 2021 |
| Epidemiology and risk factors for invasive fungal infections during induction chemotherapy for newly diagnosed acute myeloid leukemia: a retrospective cohort study MY Lien, CH Chou, CC Lin, LY Bai, CF Chiu, SP Yeh, MW Ho PloS one 13 (6), e0197851, 2018 | 63 | 2018 |
| A targeted next‐generation sequencing in the molecular risk stratification of adult acute myeloid leukemia: implications for clinical practice PH Lin, HY Li, SC Fan, TH Yuan, M Chen, YH Hsu, YH Yang, LY Li, ... Cancer medicine 6 (2), 349-360, 2017 | 61 | 2017 |
| Ursolic acid induces apoptosis and autophagy in oral cancer cells CW Lin, HK Chin, SL Lee, CF Chiu, JG Chung, ZY Lin, CY Wu, YC Liu, ... Environmental toxicology 34 (9), 983-991, 2019 | 58 | 2019 |
| Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of … T Satoh, YK Kang, Y Chao, MH Ryu, K Kato, H Cheol Chung, JS Chen, ... Gastric Cancer 23, 143-153, 2020 | 57 | 2020 |
| A triterpenoid from wild bitter gourd inhibits breast cancer cells LY Bai, CF Chiu, PC Chu, WY Lin, SJ Chiu, JR Weng Scientific reports 6 (1), 22419, 2016 | 55 | 2016 |
| G15, a GPR30 antagonist, induces apoptosis and autophagy in human oral squamous carcinoma cells LY Bai, JR Weng, JL Hu, D Wang, AM Sargeant, CF Chiu Chemico-biological interactions 206 (2), 375-384, 2013 | 55 | 2013 |
